A novel insulinotropic mechanism of whole grain‐derived γ‐oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet

Article date: September 2015

By: Chisayo Kozuka, Sumito Sunagawa, Rei Ueda, Moritake Higa, Yuzuru Ohshiro, Hideaki Tanaka, Chigusa Shimizu‐Okabe, Chitoshi Takayama, Masayuki Matsushita, Masato Tsutsui, Shogo Ishiuchi, Masanori Nakata, Toshihiko Yada, Jun‐ichi Miyazaki, Seiichi Oyadomari, Michio Shimabukuro, Hiroaki Masuzaki, in Volume 172, Issue 18, pages 4519-4534

Background and Purpose

γ‐Oryzanol, derived from unrefined rice, attenuated the preference for dietary fat in mice, by decreasing hypothalamic endoplasmic reticulum stress. However, no peripheral mechanisms, whereby γ‐oryzanol could ameliorate glucose dyshomeostasis were explored. Dopamine D2 receptor signalling locally attenuates insulin secretion in pancreatic islets, presumably via decreased levels of intracellular cAMP. We therefore hypothesized that γ‐oryzanol would improve high‐fat diet (HFD)‐induced dysfunction of islets through the suppression of local D2 receptor signalling.

Experimental Approach

Glucose metabolism and regulation of molecules involved in D2 receptor signalling in pancreatic islets were investigated in male C57BL/6J mice, fed HFD and treated with γ‐oryzanol . In isolated murine islets and the beta cell line, MIN6 , the effects of γ‐oryzanol on glucose‐stimulated insulin secretion (GSIS) was analysed using siRNA for D2 receptors and a variety of compounds which alter D2 receptor signalling.

Key Results

In islets, γ‐oryzanol enhanced GSIS via the activation of the cAMP/PKA pathway. Expression of molecules involved in D2 receptor signalling was increased in islets from HFD‐fed mice, which were reciprocally decreased by γ‐oryzanol. Experiments with siRNA for D2 receptors and D2 receptor ligands in vitro suggest that γ‐oryzanol suppressed D2 receptor signalling and augmented GSIS.

Conclusions and Implications

γ‐Oryzanol exhibited unique anti‐diabetic properties. The unexpected effects of γ‐oryzanol on D2 receptor signalling in islets may provide a novel; natural food‐based, approach to anti‐diabetic therapy.

DOI: 10.1111/bph.13236

View this article